Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Super-Affinity Antibody

InVivoMAb Anti-Candida albicans HSP90 Antibody (Iv0155)

Catalog #:   VXX02301 Specific References (30) DATASHEET
Host species: Human
Isotype: IgG1
Applications: Blocking, ELISA
Accession: P46598
Overview

Catalog No.

VXX02301

Species reactivity

Candida albicans

Host species

Human

Isotype

IgG1

Clonality

Monoclonal

Target

Heat shock protein 90 homolog, HSP90, CAALFM_C702030WA, CaJ7.0234, CaO19.13868, CaO19.6515

Concentration

1 mg/ml

Endotoxin level

Please contact with the lab for this information.

Purity

>95% as determined by SDS-PAGE.

Purification

Protein A/G purified from cell culture supernatant.

Accession

P46598

Applications

Blocking, ELISA

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.

Clone ID

Iv0155

Data Image
References

Extracellular Hsp90 of Candida albicans contributes to the virulence of the pathogen by activating the NF-κB signaling pathway and inducing macrophage pyroptosis., PMID:39522202

Potential of Polyethyleneimine as an Adjuvant To Prepare Long-Term and Potent Antifungal Nanovaccine., PMID:35651617

The Role of B-Cells and Antibodies against Candida Vaccine Antigens in Invasive Candidiasis., PMID:34696267

Chitosan hydrogel loaded with recombinant protein containing epitope C from HSP90 of Candida albicans induces protective immune responses against systemic candidiasis., PMID:33482211

Heat shock protein 90 localizes to the surface and augments virulence factors of Cryptococcus neoformans., PMID:28783748

Structural characterization of low molecular weight polysaccharide from Astragalus membranaceus and its immunologic enhancement in recombinant protein vaccine against systemic candidiasis., PMID:27106150

Molecular adjuvants based on nonpyrogenic lipophilic derivatives of norAbuMDP/GMDP formulated in nanoliposomes: stimulation of innate and adaptive immunity., PMID:25630814

Serum antibody signature directed against Candida albicans Hsp90 and enolase detects invasive candidiasis in non-neutropenic patients., PMID:25377742

Candida antigens and immune responses: implications for a vaccine., PMID:24957934

Adjuvant effect of polysaccharide from fruits of Physalis alkekengi L. in DNA vaccine against systemic candidiasis., PMID:24815404

Nonspecific effect of Mycograb on amphotericin B MIC., PMID:22508314

Dose range evaluation of Mycograb C28Y variant, a human recombinant antibody fragment to heat shock protein 90, in combination with amphotericin B-desoxycholate for treatment of murine systemic candidiasis., PMID:21502626

Metallochelating liposomes with associated lipophilised norAbuMDP as biocompatible platform for construction of vaccines with recombinant His-tagged antigens: preparation, structural study and immune response towards rHsp90., PMID:21256901

The use of hybrid phage displaying antigen epitope and recombinant protein in the diagnosis of systemic Candida albicans infection in rabbits and cancer patients., PMID:20884151

Systemic and mucosal immunization with Candida albicans hsp90 elicits hsp90-specific humoral response in vaginal mucosa which is further enhanced during experimental vaginal candidiasis., PMID:18608941

Efungumab and caspofungin: pre-clinical data supporting synergy., PMID:18299636

Protective immune responses against systemic candidiasis mediated by phage-displayed specific epitope of Candida albicans heat shock protein 90 in C57BL/6J mice., PMID:16842891

A randomized, blinded, multicenter trial of lipid-associated amphotericin B alone versus in combination with an antibody-based inhibitor of heat shock protein 90 in patients with invasive candidiasis., PMID:16619152

Fungal heat-shock proteins in human disease., PMID:16438680

Fungal antigens expressed during invasive aspergillosis., PMID:16040983

Prophylactic vaccination with phage-displayed epitope of C. albicans elicits protective immune responses against systemic candidiasis in C57BL/6 mice., PMID:15963364

Comparison of protective effect of protein and DNA vaccines hsp90 in murine model of systemic candidiasis., PMID:15954537

The role of antibodies against hsp90 in the treatment of fungal infections., PMID:12942149

Preclinical assessment of the efficacy of mycograb, a human recombinant antibody against fungal HSP90., PMID:12821470

Isolation and partial characterization of Hsp90 from Candida albicans., PMID:12661902

Genistein effects on growth and cell cycle of Candida albicans., PMID:11287745

Isolation and identification of a 92-kDa stress induced protein from Candida albicans., PMID:10872511

Estrogen effects on Candida albicans: a potential virulence-regulating mechanism., PMID:10762574

Preliminary assessment of a human recombinant antibody fragment to hsp90 in murine invasive candidiasis., PMID:7539475

The role of hsp90 in fungal infection., PMID:1466751

Datasheet
$ 372
Product specifications
100 μg 372 1 mg 1486

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

InVivoMAb Anti-Candida albicans HSP90 Antibody (Iv0155) [VXX02301]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only